How Should Gastroparesis Be Diagnosed in 2026?

Gastroparesis diagnosis requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Gastroparesis diagnosis: practical clinical approach

This page focuses on Gastroparesis diagnosis with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Gastroparesis diagnosis

• ACG Clinical Guidelines
• PubMed literature search for Gastroparesis diagnosis

Clinical takeaway: For Gastroparesis diagnosis, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

The diagnosis has three components

Typical symptoms include nausea, vomiting, early satiety, postprandial fullness and upper abdominal discomfort. But these overlap with functional dyspepsia, medication effects and gastric outlet obstruction. Objective delayed emptying is therefore required.

Use a validated gastric emptying test

Scintigraphic gastric emptying of a standardized solid meal over four hours remains the best-established test. A short two-hour study can miss delayed emptying. Stable isotope breath testing can be an alternative in selected settings, but local validation matters.

Control confounders

Marked hyperglycemia slows gastric emptying. Opioids and anticholinergics can delay it; prokinetics accelerate it. GLP-1 receptor agonists and dual incretin agents can produce clinically meaningful gastric retention in some patients. Testing should be planned so that the result reflects the patient’s underlying physiology as accurately as possible.

Endoscopy has a specific role

EGD is useful to exclude outlet obstruction and mucosal disease when indicated, but retained food seen at endoscopy does not by itself establish gastroparesis. Retention can reflect inadequate fasting, medication effects or acute illness.

Practical clinical algorithm

1. Confirm chronic compatible symptoms and identify weight/nutrition consequences.
2. Review diabetes control and medications that delay or accelerate emptying.
3. Exclude mechanical obstruction with endoscopy or imaging when clinically appropriate.
4. Perform a standardized four-hour gastric emptying study.
5. Interpret the result alongside symptoms rather than diagnosing from delay alone.
6. If emptying is normal, reconsider functional dyspepsia, rumination, cyclic vomiting and other mimics.

Common mistakes to avoid

• Diagnosing gastroparesis from symptoms alone.
• Using only a two-hour gastric emptying study.
• Calling retained food at EGD diagnostic.
• Testing during uncontrolled hyperglycemia without considering its effect.
• Ignoring GLP-1 receptor agonists and opioids.

Trainee takeaway

Gastroparesis is a symptom-plus-physiology diagnosis. Exclude obstruction, control confounders and use a standardized four-hour emptying study.

Frequently asked questions

Is a two-hour gastric emptying test adequate?

Current AGA guidance suggests against two-hour or shorter testing when establishing the diagnosis; four-hour testing improves detection.

Does retained food during EGD prove gastroparesis?

No. It raises suspicion but is not sufficiently specific.

Should GLP-1 therapy always be stopped before testing?

Medication management should be individualized because the clinical question may be whether the drug itself is contributing. Document exposure and follow local testing protocols.

Suggested free reading

Continue with these free books by Dr. Alan B. R. Thomson:

• Practice Review in GI and Hepatopancreatobiliary – Part 1: GI
• The Physiology and Pathophysiology of Gastrointestinal and Hepatopancreaticobiliary Disorders

References

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

2. Thomson ABR. The Physiology and Pathophysiology of Gastrointestinal and Hepatopancreaticobiliary Disorders. CAPstone Academic Publishers; 2014.

3. Staller K, Parkman HP, Leiman DA, et al. AGA Clinical Practice Guideline on the Management of Gastroparesis. Gastroenterology. 2025. doi:10.1053/j.gastro.2025.08.004.

4. Camilleri M, Kuo B, Nguyen L, et al. ACG Clinical Guideline: Gastroparesis. Am J Gastroenterol. 2022;117:1197-1220.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.